Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA
Atara Biotherapeutics (ATRA) Stock Price & Analysis
904 Followers
ATRA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.20 - $5.64
Previous Close$0.65
Volume2.45M
Average Volume (3M)3.97M
Market Cap
$66.03M
Enterprise Value$12.13M
Total Cash (Recent Filing)$102.41M
Total Debt (Recent Filing)$48.51M
Price to Earnings (P/E)-0.2
Beta2.17
Next Earnings
Feb 27, 2024EPS Estimate
-$0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.77
Shares Outstanding101,922,250
10 Day Avg. Volume5,668,555
30 Day Avg. Volume3,966,223
Standard Deviation0.26
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-1.30
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.92
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.04
Forecast
1Y Price Target
$4.80Price Target Upside640.97% Upside
Rating ConsensusHold
Number of Analyst Covering8
Atara Biotherapeutics News
Ownership Overview
4.02% Insiders
23.18% Mutual Funds
46.36% Other Institutional Investors
26.45% Public Companies and Individual Investors
ATRA FAQ
What was Atara Biotherapeutics’s price range in the past 12 months?
Atara Biotherapeutics lowest stock price was $0.20 and its highest was $5.64 in the past 12 months.
What is Atara Biotherapeutics’s market cap?
Currently, no data Available
When is Atara Biotherapeutics’s upcoming earnings report date?
Atara Biotherapeutics’s upcoming earnings report date is Feb 27, 2024 which is in 85 days.
How were Atara Biotherapeutics’s earnings last quarter?
Atara Biotherapeutics released its earnings results on Nov 01, 2023. The company reported -$0.66 earnings per share for the quarter, missing the consensus estimate of -$0.623 by -$0.037.
Is Atara Biotherapeutics overvalued?
According to Wall Street analysts Atara Biotherapeutics’s price is currently Undervalued.
Does Atara Biotherapeutics pay dividends?
Atara Biotherapeutics does not currently pay dividends.
What is Atara Biotherapeutics’s EPS estimate?
Atara Biotherapeutics’s EPS estimate is -$0.46.
How many shares outstanding does Atara Biotherapeutics have?
Atara Biotherapeutics has 101,922,250 shares outstanding.
What happened to Atara Biotherapeutics’s price movement after its last earnings report?
Atara Biotherapeutics reported an EPS of -$0.66 in its last earnings report, missing expectations of -$0.623. Following the earnings report the stock price went down -2.326%.
Which hedge fund is a major shareholder of Atara Biotherapeutics?
Among the largest hedge funds holding Atara Biotherapeutics’s share is Baupost Group LLC. It holds Atara Biotherapeutics’s shares valued at 14M.
---
Atara Biotherapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$4.80 (640.97% Upside)
$4.80 (640.97% Upside)
Blogger Sentiment
Bullish
ATRA Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 510.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $165.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-85.29%
12-Months-Change
Fundamentals
Return on Equity
-425.97%
Trailing 12-Months
Asset Growth
-48.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Atara Biotherapeutics
Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.
---
Top 5 ETFs holding ATRA
Vanguard Total Stock Market ETF
$3.50M
Vanguard Health Care ETF
$358.94K
Schwab U.S. Broad Market ETF
$38.44K
iShares Russell 3000 ETF
$17.20K
Vanguard Russell 3000 ETF
$9.80K
Up to five ETFs with an Outperform Smart Score that hold ATRA. The ETFs are listed according to market value of ATRA within the ETF
---